Company news

Alphamab Oncology news in 2020

Alphamab Oncology's news releases, calls and decks from 2020, newest first.

View company

Alphamab Oncology: Received U.S. FDA IND Approval to Initiate A Phase II Clinical Trial of KN046 For NSCLC in the United States

April 16, 2020

Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib)

March 27, 2020